AU1507199A — Novel pyrimidine-5-carboxamide derivatives
Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1999-07-05 · 27y expired
What this patent protects
Pyrimidine-5-carboxamide derivatives represented by a general formula (I) or salts thereof <CHEM> Äwherein each symbol has the following meaning; X: O, S, NR<1>, CO, NR<1>CO, CONR<1>, C=N-OR<1> or a bond, Y: a lower alkylene group which may be s…
USPTO Abstract
Pyrimidine-5-carboxamide derivatives represented by a general formula (I) or salts thereof <CHEM> Äwherein each symbol has the following meaning; X: O, S, NR<1>, CO, NR<1>CO, CONR<1>, C=N-OR<1> or a bond, Y: a lower alkylene group which may be substituted by OR<1> or -NHR<1>, or a bond, Z: O, NR<2> or a bond, A: H, or a lower alkyl which may have a substituent, a -CO-lower alkyl which may have a substituent, an aryl which may have a substituent, a heteroaryl which may have a substituent, a cycloalkyl which may have a substituent or a nitrogen-containing saturated heterocyclic group which may have a substituent, B: an aryl which may have a substituent or a heteroaryl group which may have a substituent, R<1>, R<2>: H, a lower alkyl or a -CO-lower alkyl groupÜ.
Drugs covered by this patent
- Inrebic (FEDRATINIB HYDROCHLORIDE) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.